Piper Sandler lowers Kimberly Clark stock price target to $145 on near-term pressure

Kimberly Clark (KMB) is grappling with near-term competitive pressures, particularly aggressive private label discounting in the diaper market, prompting Piper Sandler to reduce its price target to $145 from $149 and lower 2025/2026 EPS estimates, though maintaining an Overweight rating. This comes after KMB reported a Q2 2025 EPS beat but a revenue miss, with the stock currently trading near its 52-week low of $121.02. While KMB has postponed planned promotions, analysts present a mixed outlook, with some retaining positive long-term views citing portfolio reshaping and innovation, while others, like Evercore ISI, adjust targets based on short-term sales expectations.

Analysis

Kimberly-Clark (KMB) is navigating significant near-term headwinds, primarily from intensified private label competition that has slowed North American diaper category growth to just 1.0% in August. This pressure prompted Piper Sandler to reduce its price target to $145 and lower its fiscal 2025 and 2026 EPS forecasts to $7.41 and $7.85, respectively. In response, KMB has postponed new product promotions until Q4 2025, anticipating more favorable pricing dynamics. The market sentiment is mixed; while the stock trades near its 52-week low and four analysts have revised earnings estimates downward, the company recently reported a Q2 2025 EPS of $1.92, beating forecasts by 16.36%. However, this was overshadowed by a significant revenue miss of $4.16 billion against a $4.77 billion expectation. Analyst ratings reflect this dichotomy: Goldman Sachs raised its price target to $145, citing a 5% volume-led growth, while Evercore ISI trimmed its target to $150 due to near-term sales concerns. Despite the short-term challenges, a positive long-term outlook is maintained by some analysts, predicated on a reshaped portfolio, a robust 2026 innovation pipeline, and a solid 4.09% dividend yield, suggesting a potential value case for the stock.

Key Decisions for Investors

• Investors should exercise caution in the near term, as sustained promotional pressure from private label competitors could further impact KMB's margins and market share before the planned Q4 2025 innovations take effect.
• For long-term, income-focused investors, the stock's position near its 52-week low combined with a 4.09% dividend yield may represent an attractive entry point, provided they have confidence in management's ability to execute its long-term innovation and portfolio strategy.
• Monitor key upcoming catalysts, including commentary on pricing dynamics in Q3 results, the strategic direction under the new President of North America, and the market reception of new products in late 2025.